跳至主要内容
临床试验/RPCEC00000400
RPCEC00000400已完成未知

Validation study for the clinical use of the Hipermax BF automatic blood pressure measurement device in the general population. - VALIDAC HIPERMAX-BF

Institute of Cardiology and Cardiovascular Surgery (ICCCV)0 个研究点目标入组 85 人开始时间: 2022年2月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
85

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
12 years 至 one(—)
性别
All

入选标准

  • 1. In all cases, informed consent will be obtained.
  • 2. Age 12 years or older, not pregnant
  • 3. No arrhythmias (Electrocardiogram)
  • 4. Blood pressure in the SBP 80-220 mmHg and DBP 50-120 mmHg ranges (Initial blood pressure measurement)

排除标准

  • 1. Refusal to be part of the study.
  • 2. Belonging to a group classified as a special population: children under 12 years of age or pregnant women.
  • 3. K5 Korotkoff sound not audible in one subject.
  • 4. Cardiac arrhythmias

研究者

发起方
Institute of Cardiology and Cardiovascular Surgery (ICCCV)

相似试验